CIP
RGEN icon

Chartwell Investment Partners’s Repligen RGEN Stock Holding History

Chartwell Investment Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,914
Closed -$1.13M – 442
2021
Q3 		$1.13M Hold
3,914
– – 0.04% 365
2021
Q2 		$781K Hold
3,914
– – 0.02% 390
2021
Q1 		$761K Hold
3,914
– – 0.02% 375
2020
Q4 		$750K Sell
3,914
-10,516
-73% -$1.91M 0.02% 377
2020
Q3 		$2.13M Buy
+14,430
New +$2.06M 0.08% 265

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Chartwell Investment Partners's RGEN Position: Q4 2021 in Review

Chartwell Investment Partners sold out of Repligen (RGEN) in Q4 2021, closing a stake of 3,914 shares — an estimated $1.13M sold.

Chartwell Investment Partners first reported a position in RGEN in Q3 2020 and held it in 5 quarters. The position peaked at $2.13M in Q3 2020. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Chartwell Investment Partners reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 3,914 Repligen shares in Q4 2021, an estimated $1.13M.
  • Chartwell Investment Partners first reported a position in Repligen in Q3 2020 and held it in 5 quarters.
  • Chartwell Investment Partners's Repligen position peaked at $2.13M in Q3 2020.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Chartwell Investment Partners's 13F filing for Q4 2021, filed 15 Feb 2022.